Publicacions
-
Delgadillo V, O'Callaghan-Gordo M, Artuch-Iriberri R, Montero-Sanchez R and Pineda M.
Genistein supplementation in patients affected by Sanfilippo disease
JOURNAL OF INHERITED METABOLIC DISEASE . 34(5): 1039-1044. Nº de cites: 77
-
Velasco-Sánchez D, Aracil A, Montero-Sanchez R, Mas A, Jiménez L, O'Callaghan-Gordo M, Tondo M, Capdevila A, Blanch J, Artuch-Iriberri R and Pineda M.
Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich's Ataxia
Cerebellum . 10(1): 1-8. Nº de cites: 126
-
Serrano M, García-Silva MT, Martin-Hernandez E, O'Callaghan-Gordo M, Quijada P, Martinez-Aragón A, Ormazabal-Herrero A, Blázquez A, Martín-Mateos MA, Briones P, López-Gallardo E, Ruiz-Pesini E, Montoya J, Artuch-Iriberri R and Pineda M.
Kearns-Sayre syndrome: Cerebral folate deficiency, MRI findings and new cerebrospinal fluid biochemical features
Mitochondrion . 10(5): 429-432. Nº de cites: 47
-
Pineda M, Montero-Sanchez R, Aracil A, O'Callaghan-Gordo M, Mas A, Espinos C, Martinez-Rubio D, Palau F, Navas P, Briones P and Artuch-Iriberri R.
Coenzyme Q10-Responsive Ataxia: 2-Year-Treatment Follow-up
MOVEMENT DISORDERS . 25(9): 1262-1268. Nº de cites: 46
-
Pineda M, Pérez-Poyato M S, O'Callaghan-Gordo M, Vilaseca MA, Pocovi M, Domingo R, Portal LR, Pérez AV, Temudo T, Gaspar A, Peñas JJ, Roldán S, Fumero LM, de la Barca OB, Silva MT, Macías-Vidal J and Coll MJ.
Clinical experience with miglustat therapy in pediatric patients with Niemann Pick disease type C: A case series
MOLECULAR GENETICS AND METABOLISM . 99(4): 358-366. Nº de cites: 93
-
Roche A, Mora J, Perez Mdel M, Gean Molins E, Pérez-Dueñas B, O'Callaghan-Gordo M, Catala J, de Torres C, Cruz-Martínez O, Prat-Bartomeu J and Parareda A.
Axenfeld-Rieger Ocular Anomaly and Retinoblastoma Caused by Constitutional Chromosome 13q Deletion
PEDIATRIC BLOOD & CANCER . 54(3): 480-482. Nº de cites: 3
-
Pineda M, R-Palmero A, Baquero M, O'Callaghan-Gordo M, Aracil A, van der Knaap M and Scheper GC.
Vanishing white matter disease associated with progressive macrocephaly
Neuropediatrics . 39(1): 29-32. Nº de cites: 5
-
Cortés-Saladelafont E, Molero M, Duarte S, Casado-Rio M, Sierra-March C, O'Callaghan-Gordo M, Sanmarti FX, Fons-Estupina C, González V, Pérez-Dueñas B, Poo P, Ramos F, García-Alix A, Armstrong-Moron J, Artuch-Iriberri R and Garcia-Cazorla A.
Supplementation with pyridoxal phosphate may be useful in diverse neuropediatric disorders.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY . : .
-
Rodriguez H, Ormazabal-Herrero A, Casado-Rio M, Arias AY, Oliva-Mussara C, Barranco-Altirriba M, Ricard Casadevall Llandrich, Francisco García Cuyás, Nascimento-Osorio A, Ortez-Gonzalez CI, Natera-de Benito D, Armangue-Salvador T, O'Callaghan-Gordo M, Julià-Palacios NA, Darling A, Ortigoza-Escobar JD, Fons-Estupina C, Garcia-Cazorla A, Perera A and Artuch-Iriberri R.
Cerebrospinal Fluid Homovanillic and 5-Hydroxyindoleacetic Acids in a Large Pediatric Population; Establishment of Reference Intervals and Impact of Disease and Medication.
CLINICAL CHEMISTRY . : .
-
Rossi A, Romano R, Fecarotta S, Dell'Anno M, Pecorella V, Passeggio R, Zancan S, Parenti G, Santamaria F, Borgia F, Deodato F, Funghini S, Rupar CA, Prasad C, O'Callaghan-Gordo M, Mitchell JJ, Valsecchi MG, la Marca G, Galimberti S, Auricchio A and Brunetti-Pierri N.
Multi-year enzyme expression in patients with mucopolysaccharidosis type VI after liver-directed gene therapy.
Med . : .